BLACK WEEKSVials −15% · kits −10% · rest −5%met codeGratis verzending binnen Duitsland vanaf €200

Deze pagina is automatisch vertaald en kan fouten bevatten. Ben je moedertaalspreker? We horen graag je feedback en verbeteringen.Feedback sturen

The Peptide Desk The Peptide Desk
Minoxidil, productfoto

Labrapport

PDF
Getest
Getest
Minoxidil 5mg × 100 Tabs
Lab
Analiza Białek
Datum
October 2026
Resultaat
5.33 mg per tablet (5 mg label)
Bestelnr.
Wachtwoord

Onafhankelijk getest, met het wachtwoord direct bij het lab te controleren.

Hair & Skin

Minoxidil

Hair & Skin

Bestelling

Stukprijs - Gratis verzending binnen Duitsland vanaf €200 tijdens de Black Weeks
  • DHL met tracking
  • Discrete verpakking

4.6 van 5 op Trustpilot73 reviews

In één oogopslag

Minoxidil in cijfers

De kerncijfers uit ons lexicon. Sleep het punt langs de curve om te zien hoeveel er na één dosis rekenkundig nog over is.

Volledig lexiconartikel

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~4 hours

Half-life ~4 hours
After 8 hours: 25 %
Hour 450 %Hour 825 %Hour 1212.5 %Hour 203.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

about4hours

Class
Vasodilatororal, low-dose
Use
Oral1x per day
Sizes
5 mg1 size in the shop

Kennis

Alles over Minoxidil

Uitgebreide informatie volgt binnenkort.

Dosering

Doseringsinformatie laden …

Meer in het lexicon

FAQ

Veelgestelde vragen

Bronnen bij elk antwoord: lexiconartikel

Nog een vraag?

Schrijf ons, ons team helpt je verder.

How does minoxidil act on hair?

It is not fully understood. In animal models minoxidil shortens the resting phase, resting follicles switch to growth earlier, the growth phase gets longer and the follicle larger. The active form is the sulfate, which opens potassium channels. Such channels were found in the dermal papilla of human hair follicles. In culture minoxidil and a channel blocker cancelled each other out.

Is minoxidil approved as a tablet?

The compound is: ChEMBL lists minoxidil with phase 4 as the highest phase and first approval in 1979. As a tablet it lowers blood pressure via the vessels. For hair loss the low-dose tablet is used off-label. A phase 3 trial in women is running on the registry, one with tablets under the tongue in men has been completed.

Is the tablet better than the solution applied to the scalp?

In a double-blind trial with 90 men (68 analysed) the tablet was not superior after 24 weeks. The gain in hair density was somewhat higher at the vertex, but not statistically significant. Only the photo assessment put the tablet ahead at the vertex. Its advantage is more about daily life: no daily application. The solution itself is well studied: in a trial with 393 men the higher-concentration solution grew clearly more hair over 48 weeks than the lower-concentration one or placebo.

Why does it not work equally for everyone?

Minoxidil is activated in the hair follicle by the enzyme sulfotransferase. In a study with 41 patients hair loss improved in 63.4 percent after 6 months, more often in men than in women. Surprisingly, patients with low enzyme activity responded better (85 against 43 percent). The authors see this as a way to estimate beforehand who benefits.

Which side effects were seen?

In the largest analysis with 1,404 patients increased body hair was most common (15.1 percent). Lightheadedness (1.7), fluid retention (1.3), racing heart (0.9), headache (0.4), swelling around the eyes (0.3) and sleep problems (0.2 percent) were rare, 1.7 percent stopped. In a small trial in men almost half had more body hair.

Does it also help with diffuse shedding?

In chronic telogen effluvium, long-lasting diffuse shedding without bald patches, it was studied in 36 women. The shedding score fell from 5.64 by 1.7 points after 6 months and by 2.58 points after 12 months. Blood pressure barely changed, 13 women developed more facial hair. It was a retrospective analysis without placebo.

How good is the overall evidence?

A review found 17 studies with 634 patients in total up to April 2020, mostly on pattern hair loss, plus other forms. It rates the tablet as effective and well tolerated for healthy people who struggle with the solution. According to the authors larger randomised trials comparing doses are still missing.

Gerelateerd

Gerelateerde producten